Advanced Search
CHEN Shu-guang, ZHAO Haitao, ZHANG Ning, HAN Kai, WANG Shao-bin, QU Qiang, WEI Xue, RUI Jingan. A TACE Oriented Comprehensive Therapy for Unresectable Primary Liver Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(08): 505-506. DOI: 10.3971/j.issn.1000-8578.1275
Citation: CHEN Shu-guang, ZHAO Haitao, ZHANG Ning, HAN Kai, WANG Shao-bin, QU Qiang, WEI Xue, RUI Jingan. A TACE Oriented Comprehensive Therapy for Unresectable Primary Liver Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(08): 505-506. DOI: 10.3971/j.issn.1000-8578.1275
shu

A TACE Oriented Comprehensive Therapy for Unresectable Primary Liver Cancer

  • Department of General Surgery, Beijing Union Hospital, Chinese Academy of Medical Sciences, Beijing 100032, China

More Information
  • Corresponding author:

    CHEN Shu-guang

  • Received Date: October 17, 2004
  • Revised Date: December 19, 2004
    Abstract
  • Objective 　To study the therapeutic measures of unresectable primary liver cancer(PLC) . Methods 　From January 1991 to March 2000, the clinical data of 192 patients with unresectable primary liver cancer were analyzed ret rospectively with clinical data, treatment measure and followed-up data. Results 　169 patient s were followed-up 21 cases accepted the second line operation explore of which, 13 cases accepted the liver section and 1 case the liver f reeze operation. The overall 12, 32 and 52 year survival rate was 73. 6 %, 27. 1 %, 9. 2 %, respectively. Conclusion 　Unresectable primary liver cancer should be treated by the TACE oriented comprehensive therapy.
    • FullText(HTML)
    • References (0)
    • Related Articles

  • Related Articles

    [1]WANG Hao, HUANG Huixian, LI Youran, YAN Yuehua, YI Jiaqin, LIU Xiaoyu, LUO Dongmei, GU Yu. Neogambogic Acid Suppresses Characteristics of Colorectal Cancer Stem Cells Through Inhibition of Wnt/β-catenin Signaling Pathway[J]. Cancer Research on Prevention and Treatment, 2025, 52(7): 554-561. DOI: 10.3971/j.issn.1000-8578.2025.24.1125
    [2]WANG Ruihua, CAI Shiliang, LIU Donghong, CHEN Hongsen, CAO Guangwen. Research Progress of Androgen/Androgen Receptor Signaling Pathway in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2023, 50(2): 180-185. DOI: 10.3971/j.issn.1000-8578.2023.22.0714
    [3]WANG Zihe, LI Zengliang, FANG Xuzhe, ZHU Jin. Research Progress on Influence of DNA Methylation on Signal Pathways Related to Invasion and Metastasis of Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(9): 956-960. DOI: 10.3971/j.issn.1000-8578.2022.22.0052
    [4]XUE Rui, GAO Jiping, YAN Xiaoru, XU Guoqiang, SONG Guohua. Effects of Autophagy-related Genes and Signal Pathways on Occurrence and Development of Oral Tumors[J]. Cancer Research on Prevention and Treatment, 2021, 48(5): 514-518. DOI: 10.3971/j.issn.1000-8578.2021.20.1377
    [5]GOU Yunjiu, MA Jilong, HAN Songchen, JIN Dacheng, CHEN Meng, WANG Bing, BAI Qizhou. CircHIPK3 Affects Malignant Phenotypes in Esophageal Squamous Cell Carcinoma by Regulating p53-Akt-Mdm2 Signaling Pathways[J]. Cancer Research on Prevention and Treatment, 2019, 46(11): 987-993. DOI: 10.3971/j.issn.1000-8578.2019.19.0386
    [6]ZHAI Linzhu, ZHAO Yuanyuan, LIN Lizhu. Current Research Status of NF-kappa B Related Molecular Pathway in Diffuse Large B Cell Lymphoma[J]. Cancer Research on Prevention and Treatment, 2016, 43(10): 903-906. DOI: 10.3971/j.issn.1000-8578.2016.10.015
    [7]GUO Zhen, JIAO Feng, JIN Ziliang, WANG Liwei. Roles of HOXB7 in Tumors and Related Signaling Pathways[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 200-203. DOI: 10.3971/j.issn.1000-8578.2015.02.022
    [8]ZHANG Juan, LIU Kangdong, GUO Lihua, DONG Ziming. Changes of Signal Transduction Pathways in Esophageal Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 943-947. DOI: 10.3971/j.issn.1000-8578.2014.08.020
    [9]WANG Jian, ZHAO Zhenchun, GUO Zhen, BAI Mingdong. Role of Wnt/PCP Signal Pathway in Colon Carcinogenesis in Experimental Rats[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 876-878. DOI: 10.3971/j.issn.1000-8578.2014.08.004
    [10]ZHANG Yu-jun, ZHOU Bo, XIE Fei. Differences of Signaling Pathway of NSP-1, NSP-2 and NSP-3 in Breast Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 153-157. DOI: 10.3971/j.issn.1000-8578.2010.02.008

Catalog

    RUI Jingan

    • Department of General Surgery, Beijing Union Hospital, Chinese Academy of Medical Sciences, Beijing 100032, China

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Get Citation
    PDF
    XML
    Article views (2862) PDF downloads (798) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：22067927 Visits today：33576

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return